EW
Erin Wilson Morgan Stanley Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Rapid7
RPD
$1.28B
| $19.84 | $22 |
11%
upside
| Equal-Weight | 2 days ago |
|
2 |
2
Align Technology
ALGN
$9.76B
| $134.70 | $732 |
443%
upside
| Outperform | 4 years ago |
|
3 |
3
Charles River Laboratories
CRL
$7.99B
| $162.31 | $385 |
137%
upside
| Neutral | 4 years ago |
|
4 |
4
IQVIA
IQV
$31.3B
| $184.08 | $265 |
44%
upside
| Outperform | 4 years ago |
|
5 |
5
Medpace
MEDP
$13.6B
| $482.34 | $205 |
58%
downside
| Outperform | 4 years ago |
|
6 |
6
Icon
ICLR
$13.7B
| $176.36 | $250 |
42%
upside
| Outperform | 4 years ago |
|
7 |
7
Elanco Animal Health
ELAN
$8.68B
| $17.47 | $38 |
118%
upside
| Outperform | 4 years ago |
|
8 |
8
Thermo Fisher Scientific
TMO
$185B
| $489.49 | $341 |
30%
downside
| Neutral | 5 years ago |
|